PTSD Clinical Trials
There are 219 actively recruiting ptsd clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include New York, New York, United States, Seattle, Washington, United States, Charleston, South Carolina, United States. Updated daily from ClinicalTrials.gov.
PTSD Trials at a Glance
219 actively recruiting trials for ptsd are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 154 trials, with the heaviest enrollment activity in New York, Seattle, and Charleston. Lead sponsors running ptsd studies include VA Office of Research and Development, The University of Texas Health Science Center at San Antonio, and Peking University.
Browse ptsd trials by phase
Top cities for ptsd trials
Understanding PTSD Clinical Trials
Clinical trials have shaped every aspect of how post-traumatic stress disorder is treated today, from the FDA approval of sertraline (Zoloft) and paroxetine (Paxil) as the first medications specifically indicated for PTSD, to the validation of prolonged exposure and cognitive processing therapy as gold-standard psychotherapies. More recently, MDMA-assisted therapy showed remarkable results in Phase 3 trials, with approximately 71 percent of participants no longer meeting diagnostic criteria for PTSD after treatment, though the FDA requested additional data in 2024. For the roughly 13 million Americans living with PTSD in any given year, clinical trials are the gateway to next-generation treatments that may offer faster relief and higher remission rates than what is currently available.
Why Consider a Clinical Trial?
Frequently Asked Questions
Common questions about PTSD clinical trials
Most PTSD trials require a confirmed diagnosis, typically verified through a structured clinical interview during the screening process. Some prevention-focused trials enroll people who have recently experienced trauma but have not yet developed full PTSD. The screening process itself is free and will clarify whether you meet the specific study criteria.
No. While some trials specifically recruit veterans or active-duty military personnel, the majority of PTSD trials are open to anyone with the diagnosis regardless of their trauma type. PTSD can result from any traumatic experience, including sexual assault, accidents, natural disasters, childhood abuse, or witnessing violence. Trials exist for all of these populations.
This depends on the type of trial. Psychotherapy trials may involve guided discussion of traumatic memories as part of the treatment protocol. Medication trials generally focus on symptom assessment and may not require detailed trauma narratives. Every trial will explain what is involved before you consent, so you can make an informed decision about your comfort level.
Many trials allow you to maintain your existing therapeutic relationship, though some psychotherapy trials may ask you to pause other trauma-focused therapy to avoid confounding the study results. Supportive therapy and non-trauma-focused treatment are usually permitted. Discuss this with both your therapist and the research team before enrolling.
PTSD trials include safety protocols such as regular symptom monitoring, 24/7 crisis contact numbers, and predetermined criteria for withdrawal if symptoms significantly worsen. Institutional review boards must approve all study procedures before the trial begins. Research staff are trained in trauma-informed care and crisis intervention.
Showing 1–20 of 219 trials